The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 30, 2021

Filed:

Aug. 04, 2016
Applicant:

Sunovion Pharmaceuticals Inc., Marlborough, MA (US);

Inventors:

Michele L. R. Heffernan, Holliston, MA (US);

Larry Wendell Hardy, Framingham, MA (US);

Scott P. Brown, Framingham, MA (US);

Lee W. Herman, Natick, MA (US);

Assignee:

Sunovion Pharmaceuticals Inc., Marlborough, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 211/22 (2006.01); C07D 401/08 (2006.01); C07D 401/14 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 405/06 (2006.01); C07D 471/04 (2006.01); C07D 487/10 (2006.01); C07D 491/107 (2006.01); C07D 311/22 (2006.01); C07D 217/24 (2006.01); C07D 223/08 (2006.01); C07D 235/12 (2006.01); C07D 237/14 (2006.01); C07D 413/06 (2006.01); C07D 241/04 (2006.01); C07D 243/08 (2006.01); C07D 471/08 (2006.01); C07D 491/048 (2006.01); C07D 267/10 (2006.01); C07D 275/04 (2006.01); C07D 211/58 (2006.01); C07D 403/06 (2006.01); C07D 405/12 (2006.01); A61P 25/28 (2006.01); C07D 417/04 (2006.01); A61P 25/18 (2006.01); C07D 513/04 (2006.01); C07D 211/42 (2006.01); C07D 295/104 (2006.01); C07D 207/36 (2006.01); C07D 213/81 (2006.01); C07D 491/20 (2006.01); C07D 249/12 (2006.01); C07D 221/20 (2006.01); C07D 295/088 (2006.01); C07D 311/58 (2006.01); C07D 207/12 (2006.01); C07D 211/44 (2006.01); C07D 265/30 (2006.01); C07D 277/66 (2006.01); C07D 295/027 (2006.01); C07D 295/073 (2006.01); C07D 295/096 (2006.01); C07D 295/108 (2006.01); C07D 307/83 (2006.01); C07D 311/08 (2006.01); C07D 413/08 (2006.01); C07D 471/10 (2006.01);
U.S. Cl.
CPC ...
C07D 401/08 (2013.01); A61P 25/18 (2018.01); A61P 25/28 (2018.01); C07D 207/12 (2013.01); C07D 207/36 (2013.01); C07D 211/42 (2013.01); C07D 211/44 (2013.01); C07D 211/58 (2013.01); C07D 213/81 (2013.01); C07D 217/24 (2013.01); C07D 221/20 (2013.01); C07D 223/08 (2013.01); C07D 235/12 (2013.01); C07D 237/14 (2013.01); C07D 241/04 (2013.01); C07D 243/08 (2013.01); C07D 249/12 (2013.01); C07D 265/30 (2013.01); C07D 267/10 (2013.01); C07D 275/04 (2013.01); C07D 277/66 (2013.01); C07D 295/027 (2013.01); C07D 295/073 (2013.01); C07D 295/088 (2013.01); C07D 295/096 (2013.01); C07D 295/104 (2013.01); C07D 295/108 (2013.01); C07D 307/83 (2013.01); C07D 311/08 (2013.01); C07D 311/22 (2013.01); C07D 311/58 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 405/06 (2013.01); C07D 405/12 (2013.01); C07D 413/06 (2013.01); C07D 413/08 (2013.01); C07D 417/04 (2013.01); C07D 471/04 (2013.01); C07D 471/08 (2013.01); C07D 471/10 (2013.01); C07D 487/10 (2013.01); C07D 491/048 (2013.01); C07D 491/107 (2013.01); C07D 491/20 (2013.01); C07D 513/04 (2013.01);
Abstract

Compounds of formula I: are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer's and Parkinson's diseases.


Find Patent Forward Citations

Loading…